View by Specialty

Trending

Image: Healio
September 20, 2024
1 min read
Save

FDA approves nasal spray as first self-administered flu vaccine

Oncology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 07, 2014
1 min read
Save

HCC inhibitor receives FDA orphan drug designation

Casi Pharmaceuticals has received an orphan drug designation from the FDA for ENMD-2076 to treat hepatocellular carcinoma, according to a press release.

SPONSORED CONTENT
July 03, 2014
1 min read
Save

NCAN polymorphism associated with HCC, alcoholic liver disease

The neurocan rs2228603 polymorphism is associated with alcoholic liver disease and hepatocellular carcinoma, according to study results.

Trending

Image: Healio
September 20, 2024
1 min read
Save

FDA approves nasal spray as first self-administered flu vaccine

SPONSORED CONTENT
July 02, 2014
1 min read
Save

High frequency of Treg cells associated with HCC

Patients with hepatocellular carcinoma had a larger number of regulatory T cells compared with controls, indicating an association between T-cell frequency and pathogenesis of cancer, according to study results.

SPONSORED CONTENT
July 01, 2014
2 min read
Save

Everolimus failed to improve OS in advanced HCC

Patients with advanced hepatocellular carcinoma who were intolerant to or experienced disease progression on sorafenib did not derive an OS benefit from everolimus, according to results of the phase 3 EVOLVE-1 trial.

SPONSORED CONTENT
June 26, 2014
1 min read
Save

HKLC scoring system improved therapy options, survival outcomes in patients with HCC

The Hong Kong Liver Cancer scoring system was effective when recommending treatment for patients with hepatocellular carcinoma compared with the Barcelona Clinic Liver Cancer system, according to data from a recent study.

SPONSORED CONTENT
June 25, 2014
1 min read
Save

Nucleos(t)ide analog therapy reduced HCC risk in patients with chronic HBV

Patients with chronic hepatitis B virus who underwent nucleos(t)ide analog therapy had a lower risk for hepatocellular carcinoma compared with untreated patients, according to new research data.

SPONSORED CONTENT
June 24, 2014
1 min read
Save

Biomarkers predicted OS after living-donor liver transplantation in patients with HCC

Pre-transplant neutrophil-lymphocyte ratio and C-reactive protein levels were effective biomarkers when detecting overall survival and disease-free survival rates among patients who underwent living-donor liver transplantation for hepatocellular carcinoma, according to recent data.

SPONSORED CONTENT
June 23, 2014
1 min read
Save

BCAA decreased risk for HCC, death among patients with cirrhosis

Patients with cirrhosis who received branched-chain amino acid supplementation had a decreased risk for hepatocellular carcinoma and mortality, according to data from a recent study.

SPONSORED CONTENT
June 19, 2014
1 min read
Save

Radioembolization induced hypertrophy, may be option for patients with liver malignancy

Radioembolization induced significantly less contralateral hypertrophy than portal vein embolization, but still may be a modality option for induction in patients with liver tumors, according to recent research data.

SPONSORED CONTENT
June 19, 2014
1 min read
Save

Cyramza fails to meet primary endpoint in hepatocellular carcinoma

Results from the phase 3 REACH trial have found that ramucirumab did not meet its primary endpoint of OS when used as a second-line treatment for hepatocellular carcinoma, manufacturer Eli Lilly said in a press release.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails